Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Patients With Chronic Migraine.
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2017
At a glance
- Drugs Erenumab (Primary)
- Indications Migraine
- Focus Registrational; Therapeutic Use
- Sponsors Amgen
- 10 Sep 2017 Results of a subgroup analysis assessing efficacy of erenumab in patient with chronic migraine with aura and without aura, were presented at the 2017 International Headache Society.
- 10 Sep 2017 Results of post hoc analysis assessing efficacy prior to week 4 in patient with chronic migraine treated with Erenumab, were presented at the 2017 International Headache Society.
- 07 Sep 2017 Data published in an Novartis Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History